# Clinical Cases: Other Gram-Negative Bacteria ## Case 1: Pseudomonas Malignant Otitis Externa ### Presentation A 72-year-old man with poorly controlled diabetes mellitus presents with severe right ear pain for 3 weeks that has progressively worsened despite treatment with topical antibiotic drops. He now reports difficulty swallowing and a new right facial droop. Examination reveals purulent discharge from the ear canal, granulation tissue at the junction of the bony and cartilaginous ear canal, and right-sided facial nerve palsy (House-Brackmann grade IV). Temperature is 38.5°C. CT scan of the temporal bone shows soft tissue in the external auditory canal with erosion of the temporal bone extending to the skull base. ### Clinical Image ![Malignant otitis externa CT scan](image_01.png) *CT scan demonstrating soft tissue density in the external auditory canal with bony erosion at the skull base, characteristic of necrotizing (malignant) otitis externa.* **Image Source**: Lecture image - Pseudomonas infections ### Questions 1. **What is the diagnosis and the most likely causative organism?** 2. **Why is this patient at particular risk for this infection?** 3. **What is the significance of the cranial nerve palsy?** 4. **What is the appropriate treatment for this condition?** ### Answers 1. **Diagnosis and organism**: The diagnosis is **malignant (necrotizing) otitis externa** caused by **Pseudomonas aeruginosa**. This is not a malignancy but a severe, invasive infection of the external ear canal that extends into the temporal bone and skull base. The characteristic findings include granulation tissue at the bony-cartilaginous junction of the ear canal, progressive bone erosion, and cranial nerve involvement in advanced cases. 2. **Risk factors**: This patient has two major risk factors: **elderly age** and **poorly controlled diabetes mellitus**. The combination of microangiopathy affecting the ear canal vasculature and impaired neutrophil function in diabetics creates a favorable environment for Pseudomonas invasion. Additionally, the relatively poor blood supply to the bony ear canal limits antibiotic delivery and immune cell access to the infected tissue. 3. **Significance of cranial nerve palsy**: The **facial nerve palsy** (cranial nerve VII) indicates extension of infection to the stylomastoid foramen or through the temporal bone. This is a poor prognostic sign indicating advanced disease. Other cranial nerves may become involved as infection spreads along the skull base, including cranial nerves IX, X, XI, and XII. Extension can lead to osteomyelitis of the skull base, meningitis, or brain abscess, all of which significantly increase mortality. 4. **Treatment**: Treatment requires prolonged **intravenous anti-pseudomonal antibiotics**, typically for 6-8 weeks or longer. First-line agents include antipseudomonal beta-lactams (piperacillin-tazobactam, ceftazidime, cefepime) or carbapenems, often combined with a fluoroquinolone (ciprofloxacin). Surgical debridement of necrotic bone may be necessary. Strict glycemic control is essential. Serial imaging and inflammatory markers (ESR, CRP) help monitor treatment response. Hyperbaric oxygen therapy may be used as adjunctive treatment. --- ## Case 2: Cholera ### Presentation A 45-year-old aid worker recently returned from a humanitarian mission in a region experiencing a cholera outbreak presents to the emergency department with profuse watery diarrhea that began 18 hours ago. She reports more than 20 episodes of stool that looks like "rice water" - clear liquid with flecks of mucus. She also has had multiple episodes of vomiting. On examination, she appears severely dehydrated with sunken eyes, dry mucous membranes, poor skin turgor, and weak pulses. Vital signs: temperature 36.2°C, heart rate 130 bpm, blood pressure 70/40 mmHg. She is alert but weak and complains of muscle cramps. ### Clinical Image ![Rice water stool](image_02.png) *Characteristic "rice-water" stool of cholera - clear fluid with mucus flecks but no blood or inflammatory cells, reflecting the secretory nature of the diarrhea.* **Image Source**: Lecture image - Vibrio cholerae infection ### Questions 1. **What is the causative organism and what toxin is responsible for the clinical syndrome?** 2. **Explain the molecular mechanism by which the toxin causes profuse diarrhea.** 3. **What is the cornerstone of treatment, and why is it so effective?** 4. **What role do antibiotics play in management?** ### Answers 1. **Organism and toxin**: The causative organism is **Vibrio cholerae** (serogroup O1 or O139), and the clinical syndrome is caused by **cholera toxin**. This is an A-B toxin with a pentameric B subunit that binds to GM1 ganglioside on intestinal epithelial cells and an A subunit that exerts the toxic effect. V. cholerae is a curved gram-negative rod with a single polar flagellum, found in contaminated water and shellfish in endemic regions. 2. **Molecular mechanism**: Cholera toxin's A subunit **ADP-ribosylates the stimulatory G protein (Gsα)**, permanently locking it in the active state. This leads to sustained activation of **adenylyl cyclase**, causing persistently elevated intracellular **cyclic AMP (cAMP)**. Elevated cAMP activates the CFTR chloride channel, causing massive secretion of chloride ions into the intestinal lumen. Sodium and water follow osmotically, producing the profuse, watery "rice-water" diarrhea that can exceed 20 liters per day in severe cases. 3. **Treatment cornerstone**: **Aggressive fluid and electrolyte replacement** is the cornerstone of treatment. Oral rehydration solution (ORS) is remarkably effective and can be lifesaving even in severe cases because the sodium-glucose cotransporter remains functional and can absorb water even when chloride secretion is maximized. Intravenous fluids (Ringer's lactate) are needed for severe dehydration or patients unable to tolerate oral intake. The mortality of cholera drops from over 50% to less than 1% with adequate rehydration. 4. **Role of antibiotics**: Antibiotics are **adjunctive therapy** that shortens the duration and volume of diarrhea, typically by 50%, and reduces bacterial shedding. First-line agents include **doxycycline** (single dose) or **azithromycin**. However, antibiotics are secondary to rehydration and should not delay or replace aggressive fluid therapy. Antibiotic resistance in V. cholerae is emerging in some regions, which may limit effectiveness. --- ## Case 3: Lyme Disease with Cardiac Manifestations ### Presentation A 28-year-old man from Connecticut presents with fatigue, intermittent palpitations, and near-syncope for the past week. He recalls an outdoor camping trip 3 weeks ago and noticed an expanding red rash on his thigh shortly thereafter that has since faded. He did not see a tick. Physical examination is notable for bradycardia with heart rate of 38 bpm. ECG shows complete heart block (third-degree AV block) with a ventricular escape rhythm. He is hemodynamically stable but is admitted for temporary pacing. ### Clinical Image ![Erythema migrans rash](image_03.png) *Erythema migrans - the classic expanding erythematous patch with central clearing ("bull's eye" pattern), the pathognomonic rash of early Lyme disease.* **Image Source**: Lecture image - Borrelia burgdorferi infection ### Questions 1. **What is the most likely diagnosis, and what organism causes this disease?** 2. **What stage of infection does this patient's cardiac manifestation represent?** 3. **How is the diagnosis confirmed, and what are the limitations of serologic testing?** 4. **What is the treatment approach for Lyme carditis?** ### Answers 1. **Diagnosis and organism**: This is **Lyme carditis** caused by **Borrelia burgdorferi**, a spirochete transmitted by Ixodes (deer) ticks. The history of an expanding "bull's eye" rash (erythema migrans), outdoor exposure in an endemic area (Connecticut, where Lyme disease was first described), and the development of heart block are classic for Lyme disease. Lyme carditis occurs in 1-5% of untreated Lyme disease cases. 2. **Stage of infection**: This represents **early disseminated Lyme disease**, occurring days to weeks after the initial infection. During this stage, spirochetes disseminate hematogenously from the initial skin inoculation site to various organs including the heart, nervous system, and joints. Cardiac manifestations typically include varying degrees of AV block, with complete heart block being the most severe. The conduction abnormality usually fluctuates and is often reversible with treatment. 3. **Diagnosis and serologic limitations**: Diagnosis is based on **clinical presentation** combined with **two-tier serologic testing** (screening with ELISA or IFA, followed by Western blot confirmation). However, serologic tests have limitations: they may be negative early in infection before antibodies develop (the "window period"), they remain positive for months to years after successful treatment, and they cannot distinguish active from past infection. In patients with erythema migrans, treatment should not be delayed for serologic confirmation. 4. **Treatment for Lyme carditis**: Patients with Lyme carditis and **high-degree AV block** (second-degree type II or third-degree) typically receive **intravenous ceftriaxone** initially due to concerns about absorption with oral medications and the need for close monitoring. Once the heart block improves, patients can transition to oral therapy (doxycycline or amoxicillin) to complete a 14-21 day course. Temporary pacing may be needed but is usually not permanent, as conduction abnormalities typically resolve within days to weeks of antibiotic treatment. Most patients do not require a permanent pacemaker.